Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

Items 1-10 of 24

Page
per page
  1. MG-115
    A2612 MG-115
     1 Citation
    Target: Proteasome
    Summary: Potent reversible proteasome inhibitor
      ≥23.08 mg/mL
  2. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      insoluble in H2O; ≥16.65 mg/mL
  3. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  4. PSI
    A1900 PSI
    Summary: Proteasome inhibitor
      ≥30.6 mg/mL
  5. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO
  6. Oprozomib (ONX-0912)
    A1934 Oprozomib (ONX-0912)
     5 Citation
    Summary: Proteasome inhibitor
      ≥26.6 mg/mL
  7. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  8. CEP-18770
    A4009 CEP-18770
     1 Citation
    Summary: Proteasome inhibitor
      insoluble in H2O; ≥16.75 mg/mL
  9. MLN2238
    A4008 MLN2238
    Summary: β5 site of the 20S proteasome inhibitor
  10. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL

Items 1-10 of 24

Page
per page